查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1986803

子宫颈癌诊断市场报告：按检测类型、年龄层和地区划分（2026-2034 年）

Cervical Cancer Diagnostics Market Report by Test Type (Pap Testing, HPV Testing, Cervical Biopsies, Colposcopy, and Others), Age Group (20 to 35 Years, Above 35 Years), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

2025年全球子宫颈癌诊断市场规模达87亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到128亿美元，2026年至2034年的复合年增长率为4.38%。

子宫颈癌的诊断依赖一系列先进的临床检测、仪器和程序，以评估异常细胞和人类乳突病毒（HPV）病毒株。这些检测包括使用电极环采集组织样本，在锥形切除术、穿刺切片检查、子宫颈刮宫术和阴道镜检查过程中对子宫颈进行详细检查。一旦检测到异常，则需进行进一步检查，例如血液检查、胸部X光片、全身电脑断层扫描（CT）、磁振造影（MRI）、正子断层扫描（PET）以及膀胱和直肠的视诊，以确定疾病进展的阶段。

性行为感染（STI）病例（如梅毒、披衣菌感染、淋病和后天免疫力缺乏缺乏症候群（HIV/AIDS））的诊断人数显着增加，导致全球HPV感染风险上升。此外，吸烟率的上升（吸烟会增加罹患子宫颈癌的风险）也是推动市场成长的主要因素之一。同时，人们对早期诊断意识的提高促进了HPV家用检测套组的广泛使用，这些试剂盒能够提供快速准确的检测结果。有利的保险报销方案也支持了市场成长。此外，人们对个人化治疗方案的需求日益增长，也扩大了对子宫颈癌诊断的需求。而且，包括手术、放射线治疗、化疗、切除术、免疫疗法和切除术在内的多种治疗方案的出现，也促进了市场成长。此外，对开发低成本、高效检测产品的日益重视，预计将进一步加速市场成长。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 调查方法

第三章执行摘要

第四章：引言

第五章：全球子宫颈癌诊断市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依测试类型划分

  • 巴氏抹片检查
  • HPV检测
  • 子宫颈切片检查
  • 阴道镜检查
  • 其他的

第七章 市场区隔：依年龄组别划分

  • 20-35岁
  • 35岁以上

第八章 市场区隔：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第九章 SWOT 分析

第十章：价值链分析

第十一章：波特五力分析

第十二章：价格分析

第十三章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Abbott Laboratories
    • Arbor Vita Corporation
    • Becton, Dickinson and Company
    • Cooper Surgical Inc.
    • F. Hoffmann-La Roche AG
    • Guided Therapeutics Inc.
    • Hologic Inc.
    • Qiagen
    • Quest Diagnostics Incorporated
    • Siemens Healthcare GmbH
Product Code: SR112026A3175

The global cervical cancer diagnostics market size reached USD 8.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 12.8 Billion by 2034, exhibiting a growth rate (CAGR) of 4.38% during 2026-2034.

Cervical cancer diagnostics rely on a series of advanced laboratory tests, tools and procedures to evaluate abnormal cells or strains of the human papillomavirus (HPV). They are performed by taking a sample of the tissue obtained through conization, punch biopsy, endocervical curettage and the electrical wire loop for a thorough examination of the cervix during colposcopy. After detection, tests like blood, chest X-ray, body computed tomography (CT) scan, magnetic resonance imaging (MRI), positron emission tomography (PET) scan and visual examination of bladder and rectum are conducted to determine the disease stage.

A considerable rise in the number of individuals diagnosed with sexually transmitted infections (STIs), such as syphilis, chlamydia, gonorrhea and acquired immune deficiency syndrome (HIV/AIDS), is escalating the risk of HPV infection worldwide. This, along with the growing number of smokers, which increases the chances of developing cervical cancer, represents one of the key factors bolstering the market growth. Furthermore, the rising awareness about early diagnosis is encouraging the adoption of HPV home testing kits that provide quick and accurate test results. The presence of favorable reimbursement policies also supports the market growth. Apart from this, rising preferences for personalized treatment plans are escalating the demand for cervical cancer diagnostics . Additionally, the availability of a range of other treatment options, including surgery, radiation therapy, chemotherapy, cone biopsy, immunotherapy and trachelectomy, is contributing to the market growth. Moreover, the growing emphasis on developing low-cost and efficient testing products is anticipated to fuel the market growth.

KEY MARKET SEGMENTATION:

Breakup by Test Type:

  • Pap Testing
  • HPV Testing
  • Cervical Biopsies
  • Colposcopy
  • Others

Breakup by Age Group:

  • 20 to 35 years
  • Above 35 years

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arbor Vita Corporation, Becton, Dickinson and Company, Cooper Surgical Inc., F. Hoffmann-La Roche AG, Guided Therapeutics Inc., Hologic Inc., Qiagen, Quest Diagnostics Incorporated and Siemens Healthcare GmbH.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the global cervical cancer diagnostics market?

2. What is the expected growth rate of the global cervical cancer diagnostics market during 2026-2034?

3. What are the key factors driving the global cervical cancer diagnostics market?

4. What has been the impact of COVID-19 on the global cervical cancer diagnostics market?

5. What is the breakup of the global cervical cancer diagnostics market based on the test type?

6. What are the key regions in the global cervical cancer diagnostics market?

7. Who are the key players/companies in the global cervical cancer diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cervical Cancer Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Pap Testing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 HPV Testing
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cervical Biopsies
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Colposcopy
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 20 to 35 years
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Above 35 years
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Arbor Vita Corporation
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Becton, Dickinson and Company
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Cooper Surgical Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 F. Hoffmann-La Roche AG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Guided Therapeutics Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 SWOT Analysis
    • 13.3.7 Hologic Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Qiagen
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Quest Diagnostics Incorporated
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Siemens Healthcare GmbH
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Cervical Cancer Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Cervical Cancer Diagnostics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Cervical Cancer Diagnostics Market: Breakup by Test Type (in %), 2025
  • Figure 5: Global: Cervical Cancer Diagnostics Market: Breakup by Age Group (in %), 2025
  • Figure 6: Global: Cervical Cancer Diagnostics Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Cervical Cancer Diagnostics (Pap Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Cervical Cancer Diagnostics (Pap Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Cervical Cancer Diagnostics (HPV Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Cervical Cancer Diagnostics (HPV Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Cervical Cancer Diagnostics (Cervical Biopsies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Cervical Cancer Diagnostics (Cervical Biopsies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Cervical Cancer Diagnostics (Colposcopy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Cervical Cancer Diagnostics (Colposcopy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Cervical Cancer Diagnostics (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Cervical Cancer Diagnostics (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Cervical Cancer Diagnostics (20 to 35 years) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Cervical Cancer Diagnostics (20 to 35 years) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Cervical Cancer Diagnostics (Above 35 years) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Cervical Cancer Diagnostics (Above 35 years) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: North America: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: North America: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: United States: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: United States: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Canada: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Canada: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Asia-Pacific: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Asia-Pacific: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: China: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: China: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Japan: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Japan: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: India: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: India: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: South Korea: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: South Korea: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Australia: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Australia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Indonesia: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Indonesia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Europe: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Europe: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Germany: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Germany: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: France: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: France: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: United Kingdom: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: United Kingdom: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Italy: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Italy: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Spain: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Spain: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Russia: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Russia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Latin America: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Latin America: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Brazil: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Brazil: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Mexico: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Mexico: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Middle East and Africa: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Middle East and Africa: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Middle East and Africa: Cervical Cancer Diagnostics Market: Breakup by Country (in %), 2025
  • Figure 70: Global: Cervical Cancer Diagnostics Industry: SWOT Analysis
  • Figure 71: Global: Cervical Cancer Diagnostics Industry: Value Chain Analysis
  • Figure 72: Global: Cervical Cancer Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cervical Cancer Diagnostics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Test Type (in Million USD), 2026-2034
  • Table 3: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Age Group (in Million USD), 2026-2034
  • Table 4: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Cervical Cancer Diagnostics Market: Competitive Structure
  • Table 6: Global: Cervical Cancer Diagnostics Market: Key Players